Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.
In May 2009 the National Institute of Allergy and Infectious Diseases hosted a workshop on serologic assays that support vaccine efficacy evaluations. The meeting promoted exchange of ideas among investigators from varying disciplines who are working on anti-infectious agent vaccines at different stages of development. The presentations and discussions at the workshop illustrated the challenges common across various pathogens with recurring themes: (1) A thorough understanding of the science regarding the pathogen and the host response to disease and immunization is fundamental to assay selection. (2) The intended use of the immunoassay data must be clearly defined to ensure appropriate specificity, accuracy, and precision; a laboratory must also commit resources to assure data quality and reliability. (3) During vaccine development, an immunoassay may evolve with respect to quality, purpose, and degree of standardization, and, in some cases, must be changed or replaced as data are accumulated. (4) Collaboration on standardized reagents and methods, harmonization efforts, and multidisciplinary teams facilitate consistent generation of quality data. This report provides guidance for effective development and utilization of immunoassays based on the lessons learned from currently licensed vaccines. Investigators are encouraged to create additional opportunities for scientific exchange, noting that the discussed themes are relevant for immunoassays used for other purposes such as therapeutics and diagnostics.
Madore
Dace V
DV
Madore Medical Writing, LLC, Pittsford, NY 14534, USA.
Meade
Bruce D
BD
Rubin
Fran
F
Deal
Carolyn
C
Lynn
Freyja
F
D007118:Immunoassay / Q000592:standards* / Q000706:statistics & numerical data*; D014612:Vaccines / Q000032:analysis* / Q000276:immunology*
D014612:Vaccines
Infect Immun. 2004 Oct;72(10):5903-9
15385492
Infection. 1984;12 Suppl 1:S44-51
6397449
Clin Microbiol Rev. 1995 Jan;8(1):22-33
7704893
J Virol Methods. 2008 Oct;153(1):43-8
18634828
Clin Infect Dis. 2005 Oct 15;41(8):1150-6
16163634
Vaccine. 2007 Sep 28;25(39-40):6852-62
17719149
Scand J Infect Dis. 1978;10(1):41-4
635475
Hum Vaccin. 2008 Nov-Dec;4(6):444-8
18728401
Infect Immun. 2003 Jan;71(1):275-86
12496177
J Virol. 2008 Mar;82(5):2350-7
18094185
Clin Diagn Lab Immunol. 1998 Jul;5(4):479-85
9665952
Cancer Immunol Immunother. 2009 Oct;58(10):1701-13
19259668
Lancet. 1986 Feb 8;1(8476):307-10
2868172
Immunol Invest. 2001 Aug;30(3):191-207
11570640
Vaccine. 2008 Jun 25;26(27-28):3516-21
18495303
Nat Rev Microbiol. 2006 Dec;4(12):932-42
17088932
J Immunol. 1971 Oct;107(4):1081-9
5315273
J Infect Dis. 1992 Mar;165(3):456-63
1538152
Vaccine. 2007 May 10;25(19):3816-26
17368878
Clin Diagn Lab Immunol. 2003 Jul;10(4):514-9
12853378
Infect Immun. 1999 Aug;67(8):4303-5
10447392
J Clin Microbiol. 2000 Jun;38(6):2043-50
10834951
Intervirology. 2007;50(1):58-62
17164559
Curr Infect Dis Rep. 2008 May;10(3):192-9
18510880
Epidemiol Infect. 2009 Dec;137(12):1684-6
19366492
Health Aff (Millwood). 2005 Jan-Feb;24(1):67-78
15647217
J Infect Dis. 2009 Jan 1;199(1):108-15
19086816
Clin Vaccine Immunol. 2009 Mar;16(3):303-11
19109448
Dev Biol Stand. 1998;95:221-2
9855435
Expert Rev Vaccines. 2005 Apr;4(2):207-18
15889994
Vaccine. 2007 May 16;25(20):4056-63
17412461
Vaccine. 2008 Sep 12;26 Suppl 4:D41-4
19230158
Clin Chem. 1979 Mar;25(3):432-8
262186
Biologicals. 2007 Jun;35(3):183-7
17241789
Clin Vaccine Immunol. 2006 Sep;13(9):1004-9
16960111
Stat Methods Med Res. 1999 Jun;8(2):135-60
10501650
PDA J Pharm Sci Technol. 1998 Mar-Apr;52(2):55-9
9610168
J Infect Dis. 1986 Jan;153(1):8-16
3484506
N Engl J Med. 1987 Oct 8;317(15):923-9
2442610
Pediatrics. 1999 Oct;104(4 Pt 1):942-50
10506239
Clin Chem. 1993 Mar;39(3):424-32
8448852
Pediatr Infect Dis J. 2000 Mar;19(3):187-95
10749457
J Virol. 2007 Sep;81(17):9443-50
17596309
Vaccine. 2008 Jul 18;26 Suppl 3:C8-14
18773534
J Clin Invest. 1973 Aug;52(8):1885-92
4719668
J Infect Dis. 2000 Nov;182(5):1331-42
11010838
J Transl Med. 2010 Mar 16;8:26
20233418
Vaccine. 2003 Sep 8;21(25-26):3542-9
12922081
Clin Diagn Lab Immunol. 2001 May;8(3):616-23
11329468
Vaccine. 2003 Jul 28;21(24):3479-82
12850364
Vaccine. 2009 Jun 24;27 Suppl 2:B112-6
19464093
Pediatrics. 1977 Nov;60(5):730-7
335348
Cancer Immunol Immunother. 2008 Mar;57(3):303-15
17721781
J Infect Dis. 1977 Aug;136 Suppl:S38-42
19543
J Immunol. 1971 Jul;107(1):123-30
5091954
Dev Biol (Basel). 2003;115:63-73
15088777
Pediatr Infect Dis J. 1997 Sep;16(9):913-4
9306493
Biologics. 2008 Sep;2(3):433-9
19707374
Pediatrics. 1995 Sep;96(3 Pt 2):570-5
7659478
Vaccine. 2003 Jul 4;21(23):3265-72
12804857
J Infect Dis. 1992 Jun;165 Suppl 1:S129-33
1588146
Infect Immun. 2001 Mar;69(3):1568-73
11179328
AMA Am J Dis Child. 1953 Sep;86(3):347-8
13091327
J Exp Med. 1969 Jun 1;129(6):1307-26
4977280
J Med Virol. 1989 Feb;27(2):124-30
2466102
Dev Biol (Basel). 2004;116:61-6; discussion 69-76
15603184
Clin Diagn Lab Immunol. 1996 Nov;3(6):689-700
8914760
Clin Diagn Lab Immunol. 1995 Sep;2(5):590-7
8548539
J Infect Dis. 2007 Nov 1;196(9):1304-12
17922394
J Infect Dis. 1983 Jun;147(6):1100
6602191
Vaccine. 1998 Dec;16(20):1907-16
9796042
J Clin Virol. 2008 Sep;43(1):73-8
18571465
Stat Med. 2008 Oct 15;27(23):4758-78
17979212
Clin Diagn Lab Immunol. 1997 Mar;4(2):156-67
9067649
Clin Microbiol Rev. 2005 Jan;18(1):102-27
15653821
Pediatr Infect Dis J. 2004 Sep;23(9):852-6
15361726
Vaccine. 2009 Jun 24;27 Suppl 2:B117-25
19477054
J Infect Dis. 2004 Jul 15;190(2):373-8
15216475
Vaccine. 2009 Feb 5;27(6):803-14
19071179
Vaccine. 1998 Dec;16(20):1901-6
9796041
Clin Vaccine Immunol. 2009 Oct;16(10):1405-12
19656993